Skip to main content
LungLife AI, INC logo

LungLife AI, INC — Investor Relations & Filings

Ticker · LLAI ISIN · USU5500L1045 LEI · 549300VBVDIF0Y3OVI38 IL Human health and social work activities
Open in API
Filings indexed 85 across all filing types
Latest filing 2024-03-27 Report Publication Anno…
Country US United States of America
Listing IL LLAI

About LungLife AI, INC

https://lunglifeai.com

LungLife AI, INC. is a diagnostic company focused on developing clinical solutions for the early detection of lung cancer. Its principal product, the LungLB® test, is a minimally invasive liquid biopsy that analyzes biomarkers from a simple blood draw. Enhanced by artificial intelligence and machine learning, the test is designed to provide clinicians with additional information to aid in the evaluation and management of indeterminate lung nodules. The company's objective is to improve clinical decision-making and facilitate earlier diagnosis, thereby impacting patient outcomes for the deadliest form of cancer globally.

Recent filings

Filing Released Lang Actions
Notice of Results
Report Publication Announcement Classification · 100% confidence The document is a short announcement (under 5,000 characters) from LungLife AI regarding the upcoming release of their full-year results and an invitation to an investor presentation. It does not contain the actual financial results, but rather notifies the market of the date of the results and the presentation schedule. According to the 'Menu vs Meal' rule, this is a Report Publication Announcement (RPA).
2024-03-27 English
Holding(s) in Company
Major Shareholding Notification Classification · 100% confidence The document is a 'TR-1: Standard form for notification of major holdings', which is the regulatory standard in the UK for disclosing significant changes in share ownership. It explicitly identifies the issuer (LungLife AI, Inc), the person subject to the notification (Lombard Odier Asset Management), and the percentage of voting rights held (9.50%). This fits the definition of a Major Shareholding Notification (MRQ).
2024-03-26 English
Holding(s) in Company
Major Shareholding Notification Classification · 100% confidence The document is a 'TR-1: Standard form for notification of major holdings'. This is a regulatory requirement for shareholders to disclose when their voting rights in a company cross certain thresholds. The text explicitly identifies the issuer (LungLife AI, Inc) and the shareholder (Unicorn Asset Management Limited) and details the change in voting rights percentage. This fits the definition of a 'Major Shareholding Notification'.
2024-03-25 English
Admission of New Shares & PDMR Dealing
Director's Dealing Classification · 100% confidence The document is an RNS (Regulatory News Service) announcement from LungLife AI, Inc. regarding the 'Admission of New Shares' and 'PDMR Dealing'. It explicitly details transactions in the company's shares by directors (Paul Pagano, David Anderson, Gordon Roy Davis, and Andrew Boteler) in connection with a fundraising event. The document follows the standard format for reporting director dealings (PDMR notifications) and share capital changes. Since it reports personal share transactions by company directors, it is classified as a Director's Dealing (DIRS).
2024-03-22 English
Admission of New Shares & PDMR Dealing
Regulatory Filings Classification · 98% confidence The document is an official regulatory announcement from LungLife AI, Inc. regarding the admission of new shares and, crucially, a detailed appendix disclosing transactions by persons discharging managerial responsibilities (PDMRs). While it mentions share issuance, the primary regulatory purpose of the detailed appendix is to report insider dealings by directors. Therefore, it is classified as a Director's Dealing (DIRS) filing.
2024-03-22 English
Result of Special Meeting
Declaration of Voting Results & Voting Rights Announcements Classification · 98% confidence The document is an official announcement from LungLife AI, Inc. regarding the 'Result of Special Meeting'. It explicitly provides a table of voting results for four resolutions, which directly aligns with the definition for 'Declaration of Voting Results & Voting Rights Announcements' (DVA). While it also mentions a capital raise, the primary purpose and structure of the document are to report the outcome of the shareholder meeting.
2024-03-21 English

Browse filings by year

5 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.